Japan health minister to consider U.S. drug firms’ views in pricing overhaul

No Comments

healthNews

TOKYO (Reuters) – Japan will weigh the concerns of U.S. drug firms in its efforts to complete by year-end a drastic revision of its drug-pricing system, aimed at reining in medical spending and cutting the public burden, the health minister said on Friday.

Powered by WPeMatico

Leave a Reply

Your email address will not be published. Required fields are marked *